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We report a fatal case of disseminated acanthamebia-
sis caused by Acanthamoeba lenticulata (genotype T5) in 
a 39-year-old heart transplant recipient. The diagnosis was 
based on skin histopathologic results and conﬁ  rmed by iso-
lation of the ameba from involved skin and molecular analy-
sis of a partial 18S rRNA gene sequence (DF3).
A
canthamoeba is 1 of 3 genera of free-living amebae 
that commonly cause disease in humans (1). These 
protozoa have been implicated in local infections, such as 
amebic keratitis, mainly in immunocompetent contact lens 
wearers, and in the mostly fatal, granulomatous amebic 
encephalitis in immunocompromised patients with HIV/
AIDS and immunosuppressant-treated patients, including 
organ transplant recipients (2–4). Disseminated acanthame-
biasis (DA), which is deﬁ  ned as widespread extracerebral 
disease, is extremely rare, but its incidence has increased 
in recent years (5). Among DA reported, only 5 occurred in 
solid organ (3 lung and 2 kidney) transplant recipients (4). 
We report a fatal case of DA in a heart transplant recipient 
and identify Acanthamoeba lenticulata (genotype T5) as 
the cause of life-threatening disease.
The Case
A 39-year-old man from Martinique had received a 
second heart transplant in March 2004 because of chron-
ic rejection. He had received his ﬁ  rst transplant 14 years 
earlier because of alcohol-related dilated cardiomyopathy. 
Skin complications included epidermoid carcinoma on the 
right leg in 1995 and diffuse viral warts on the trunk in 
2003. Maintenance immunosuppression after the second 
heart transplant in 2004 included cyclosporine (220 mg/
day), prednisone (20 mg/day), and mycophenolate mofetil 
(500 mg/day). The latter drug was withdrawn because of 
pancytopenia. Postsurgery complications included acute 
refractory bleeding (aortic anastomosis), cytomegalovirus 
infection of the gut, bacterial pulmonary infection, and 
postoperative renal failure that required chronic hemodial-
ysis that prolonged his stay in the intensive care unit (ICU) 
to 5 months.
In January 2006, after a short visit to Martinique, the 
patient was transferred to our institution because of fever, 
dyspnea, and acute costal and back pain, with suspected 
osteitis underlying cutaneous lesions. Two months earlier, 
4 trunk and leg abscesses or carbunclelike skin lesions had 
developed. Despite oral antistaphylococcal therapy, these 
lesions spread and became ulcerated and painful. Three 
ulcerated, violaceous plaques with undermined deep-inﬁ  l-
trated margins were present: 1 on the trunk (largest diam-
eter 5 cm) (Figure, panel A) and 1 on each thigh. Three 
subcutaneous abscesses were present on the trunk and their 
puncture yielded a brown liquid. The differential diagnosis 
included pyoderma gangrenosum, neutrophilic dermatoses, 
mycobacteriosis, cutaneous bacterial infection, and calci-
phylaxis (chronic hemodialysis).
The ﬁ  rst histologic examination of a periulcerated skin 
lesion (punch biopsy specimen) showed diffuse dermal and 
hypodermal neutrophil inﬁ  ltration and sparse histiocytelike 
cells (Figure, panel B). No infectious elements were identi-
ﬁ  ed. Biologic data indicated an inﬂ  ammatory syndrome (C-
reactive protein 250 mg/L [normal <5 mg/L], procalcitonin 
25 ng/mL [normal <1 ng/mL]), with increased elevated 
circulating neutrophil counts (10.9 × 109 cells/L) and ane-
mia (hemoglobin 7 g/dL). Cultures of blood, abscess ﬂ  uid, 
and involved skin were repeatedly negative for  bacterial,           
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Figure. A) Ulcerated, violaceous plaque on the trunk of the patient 
with undermined inﬁ  ltrated peripheral walls. B) Section of the lesion 
in A showing diffuse dermal-hypodermal necrosis with neutrophil 
inﬁ  ltration (thin arrow) and sparse histiocytelike cells (thick arrow) 
(hematoxylin and eosin–stained, magniﬁ  cation  ×10). C) Surgical 
skin biopsy specimen showing amebic cysts (arrows) in the dermal-
hypodermal junction (hematoxylin and eosin–stained, magniﬁ  cation 
×20). D) Surgical skin biopsy specimen showing intravascular 
amebic trophozoite (arrow) characterized by acanthopodia, 
cytoplasmic vacuoles, and a prominent nucleolus (hematoxylin and 
eosin–stained, magniﬁ  cation ×40). Acanthamoeba lenticulata Infection
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mycotic, or parasitic agents. A computed tomographic 
body scan showed a massive abscess under the left kidney 
associated with pulmonary nodules without cutaneous cal-
ciphylaxis. Positron emission tomography scan conﬁ  rmed 
those abnormalities and showed extensive and severe bone 
osteomyelitis.
Atypical pyoderma gangrenosum with visceral in-
volvement was considered and treated with 3 intravenous 
prednisolone pulses. After minor initial improvement, the 
patient’s condition deteriorated, and 10 days later septic 
shock associated with multiorgan failure developed. Surgi-
cal periulcer skin biopsy specimens were obtained in the 
ICU and speciﬁ  c parasite investigations were conducted. 
DA was then diagnosed. Hematoxylin and eosin staining 
of histologic sections showed cysts and trophozoites (30 
μm diameter) in the dermal-hypodermal junction within 
polymorphous inﬂ  ammatory granulomas associated with 
ischemic necrosis (Figure, panels C and D). The presence 
of Acanthamoeba sp. was conﬁ  rmed by culturing amebae 
from involved skin on agar plates coated with Escherichia 
coli. In an indirect assay, the patient’s serum showed weak 
immunoﬂ   uorescence labeling against his own cultured 
cysts or vegetative amebae.
Molecular identiﬁ  cation of DNA extracted from the 
isolated amebae was made by using the UNSET method 
(6). A diagnostic small subunit rDNA fragment (ASA.S1) 
was ampliﬁ  ed by using JDP1 and JDP2 primers, and its 
differentiating fragment (DF3) was sequenced by using an 
internal 892c primer (7). The sequence of the DF3 subset 
that contains the highly variable and informative section in 
the ASA.S1 region of the Acanthamoeba isolate was visu-
ally compared with those of different published genotypes 
(T1–T15) (Table). Genotype T5 was identiﬁ  ed (European 
Molecular Biology Laboratory accession no. AM411530). 
No drug-of-choice exists for treating DA. Despite treat-
ment with pentamidine, 5-ﬂ  uorocytosine, and itraconazole, 
the infection was rapidly fatal. Although analysis of cere-
brospinal ﬂ  uid obtained on days 5 and 18 after admission to 
the ICU showed no biochemical or parasite data suggestive 
of granulomatous amebic encephalitis, callus corpus necro-
sis was observed on a computed tomographic brain scan on 
day 18. The patient died of multiorgan failure on day 23. 
Family members refused to allow an autopsy.
Conclusions
Protozoan infections are rare in heart transplant re-
cipients, unlike in lung transplant recipients (8,9). To our 
knowledge, our patient, whose DA involved skin, bones, 
lungs, intraabdominal organs, and perhaps the brain, rep-
resents the ﬁ  rst case to be reported in a heart transplant re-
cipient. In a recent review of the literature, Duarte et al. 
(4) reported 5 cases of DA in lung (60%) or kidney (40%) 
transplant recipients. DA was difﬁ  cult to diagnose in the pa-
tient, with 60% of the diagnoses made postmortem, which 
is similar to 74% of the diagnoses in 23 HIV/AIDS patients 
(2). The patient’s clinical picture was atypical because his 
lesions were pyodermalike ulcers with subcutaneous ab-
scesses, whereas the most frequently reported clinical skin 
manifestations were painful nodules, purpura, and pustules 
(10). Furthermore, the ﬁ  rst histologic examination did not 
identify cysts. Acanthamoeba trophozoites with character-
istic acanthopodia, cytoplasmic vacuoles, and a prominent 
nucleolus, especially in dermal vessels, were observed only 
after staining of the second biopsy specimen with hema-
toxylin and eosin in a context of strong clinical suspicion of 
DA. When reexamined retrospectively, the ﬁ  rst skin biopsy 
specimen contained some pathogens, but trophozoites had 
been misidentiﬁ  ed as histiocytelike cells.
Another important ﬁ  nding was the identiﬁ  cation of the 
DA-causative agent as genotype T5, which is commonly 
Table. rDNA sequences of Acanthamoeba isolate (2/533) from the patient, a keratitis isolate (GAK1), 3 environmental T5 subtypes, 
and 4 other genotypes from persons with nonkeratitis infections 
Genotype (strain)  DF3 sequence (5′ 3′)*
T5 (2/533)  CAAAACACCGCCGTTAATCCTTTTT---CGGGGGTTAACGGTTGGTGAAT
T5 (GAK1)  CAAAACACCGCCGTTAATCCTTT-----CGGGGGTTAATGGTTGGTGAAT
T5 (72/2)† CAAAACACCGCCGTTAATCCTTT-----CGGGGGTTAATGGTTGGTGAAT
T5 (PD2S)‡ CAAAACACCGCTGTTAATCCTTT-----CGGGGGTTAATAGTTGGTGAAT









*Sequence differences are shown in boldface.
†Five isolates at European Molecular Biology Laboratory (EMBL). 
‡Eight isolates at EMBL. 
§One isolate at EMBL. DISPATCHES
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found in the environment (11) and corresponds to A. len-
ticulata. This species has been isolated from nasal muco-
sa of persons without documented amebic infection (12). 
Although A. lenticulata has been shown to be pathogenic 
(12), genotype T5 was only recently isolated from a patient 
with keratitis (13). To our knowledge, our patient has the 
ﬁ  rst case in which genotype T5 is the etiologic agent of a 
nonkeratitis, life-threatening DA infection.
Acanthamoeba spp. are free-living amebae found in 
soil, water, air, humans, and various animals (14). Depend-
ing on the molecular methods used (i.e., nuclear 18S rRNA 
or 16S rRNA mitochondrial gene ampliﬁ  cation), 15 geno-
type sequences have been identiﬁ  ed in environmental and 
human strains (T1–T15, Table). While genotype T4 is the 
most prevalent (79% of isolates) (15), only 1 A. lenticulata 
strain isolated from a patient with ocular keratitis had geno-
type T5 (13).
This case should alert physicians to a rare but life-
threatening infection with A. lenticulata (genotype T5) in 
a heart transplant recipient. In organ transplant patients, 
when sterile cutaneous ulcers or subcutaneous abscesses 
develop that fail to respond to antibacterial treatments and 
pulse corticosteroids, histologic analysis should emphasize 
identifying Acanthamoeba spp.
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